Roswell Park Cancer Institute Center Support Grant

罗斯威尔帕克癌症研究所中心支持补助金

• 批准号: 7933235
• 负责人: DONALD L TRUMP
• 金额: $ 5万
• 依托单位: ROSWELL PARK CANCER INSTITUTE CORP
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2012-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7933235
• 关键词: Roswell; Park; Cancer; Institute; Center

DESCRIPTION (provided by applicant): The Roswell Park Cancer Institute (RPCI) has been continuously recognized as a Comprehensive Cancer Center since the NCI designation of such centers in 1974 and is now requesting continued federal support for the next five years. A free-standing research, education and clinical cancer care Institute, RPCI occupies a 27 acre campus near downtown Buffalo and has expanded to nearly 1.6M gsf of clinical and research space, a 16% increase since the last review period. RPCI serves a population base of ~1.5M in Western New York where the RPCI tumor registry is recording more than 3,400 new cancer patients per year. RPCI has strong collaborations with the University of Buffalo and the Hauptman-Woodward Institute for Structural Biology, but is a fully independent entity with Dr. Donald Trump, CCSG PI and RPCI President/CEO, answering only to the RPCI Board of Directors. Since the last competitive renewal, the RPCI has grown significantly as demonstrated by: 1) the recruitment of over 100 new faculty clinicians and researchers of which 43 are new CCSG members; 2) a 74% increase in total NCI funding and a 44% increase in total peer-reviewed funding; 3) a 73% increase in accrual to investigator-initiated, interventional clinical trials and a 44% increase to accrual in all interventional trials; 4) the addition of 4 new shared resources with an institutional investment of over $2.0 M and (5) the opening of a new, 177,000 gsf, state-of-the-art research building housing Program member laboratories and Shared Resources. With the growth in faculty has also come the recruitment of three Senior Leaders. In addition, a director for the newly created RPCI Office of Cancer Health Disparities Research has also been recruited. As part of the scientific growth within RPCI, a new disease-specific Research Program, the Prostate Program, has been added in this renewal bringing RPCI to a total of six Scientific Programs that also include Cancer Prevention & Population Sciences, Cell Stress & Biophysical Therapies, Genetics, Molecular Targets & Experimental Therapeutics and Tumor Immunology & Immunotherapy. With strong leadership and institutional commitment, RPCI will continue to focus on recruiting talented investigators to further expand research efforts targeting areas in genetics, investigational imaging and cancer health disparities.

描述（由申请人提供）：自 1974 年 NCI 指定罗斯威尔帕克癌症研究所 (RPCI) 以来，罗斯威尔帕克癌症研究所 (RPCI) 一直被认可为综合癌症中心，目前正在请求联邦政府在未来五年内继续提供支持。 RPCI 是一家独立的研究、教育和临床癌症护理机构，占地 27 英亩，靠近布法罗市中心，临床和研究空间已扩大至近 160 万平方英尺，自上次审查期以来增加了 16%。 RPCI 为纽约州西部约 150 万人口提供服务，RPCI 肿瘤登记处每年记录超过 3,400 名新癌症患者。 RPCI 与布法罗大学和 Hauptman-Woodward 结构生物学研究所有着密切的合作，但与 CCSG PI 和 RPCI 总裁/首席执行官 Donald Trump 博士一起是一个完全独立的实体，仅向 RPCI 董事会负责。 自上次竞争性更新以来，RPCI 已显着增长，具体表现在：1) 招募了 100 多名新的临床医生和研究人员，其中 43 名是新的 CCSG 成员； 2) NCI 资助总额增加 74%，同行评审资助总额增加 44%； 3) 研究者发起的干预性临床试验的应计增加 73%，所有干预性试验的应计增加 44%； 4) 增加 4 个新的共享资源，机构投资超过 200 万美元；(5) 开设一栋新的 177,000 gsf、最先进的研究建筑住房，用于项目成员实验室和共享资源。随着师资队伍的壮大，还招聘了三名高级领导。此外，新成立的 RPCI 癌症健康差异研究办公室还聘请了一名主任。作为 RPCI 科学发展的一部分，本次更新中增加了一个新的针对特定疾病的研究计划，即前列腺计划，使 RPCI 总共有六个科学计划，其中还包括癌症预防和人口科学、细胞应激和生物物理治疗、遗传学、分子靶标和实验治疗以及肿瘤免疫学和免疫治疗。 凭借强有力的领导和机构承诺，RPCI 将继续专注于招募有才华的研究人员，以进一步扩大针对遗传学、研究成像和癌症健康差异领域的研究工作。